Shareholders’ Equity (Deficit) (Details) - Schedule of stock warrants - Warrant [Member] - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Shareholders’ Equity (Deficit) (Details) - Schedule of stock warrants [Line Items]
Outstanding at beginning of the period	51,352,986	47,056,293
Weighted Average Exercise Price, Outstanding at beginning of the period	$ 0.17	$ 0.17
Granted during the period	22,421,026	3,582,873
Weighted Average Exercise Price, Granted during the period	$ 0.39	$ 0.2
Contractual adjustments to number of warrant shares during the period		1,949,535
Weighted Average Exercise Price, Contractual adjustments to number of warrant shares during the period		$ 0.08
Exercised during the period	(13,637,020)	(1,185,715)
Weighted Average Exercise Price, Exercised during the period	$ (0.18)	$ (0.07)
Expired during the period	(340,000)	(50,000)
Weighted Average Exercise Price, expired during the period	$ (0.23)	$ (0.4)
Outstanding at end of the period	59,796,992	51,352,986
Weighted Average Exercise Price, Outstanding at end of the period	$ 0.25	$ 0.17
Exercisable at end of the period	59,796,992	51,352,986
Weighted Average Exercise Price, Exercisable at end of the period	$ 0.25	$ 0.17
Weighted average remaining life	3 years 2 months 12 days	3 years 1 month 6 days